-
A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-15 Hongkang Wu, Kai Jin, Chee Chew Yip, Victor Koh, Juan Ye
Artificial Intelligence (AI) has become a focus of research in the rapidly evolving field of ophthalmology. Nevertheless, there is a lack of systematic studies on the health economics of AI in this field. This review examines studies from the PubMed, Google Scholar, and Web of Science databases that employed quantitative analysis, retrieved up to July 2023. Most of the studies indicate that AI leads
-
Clinical Therapeutics for Proliferative Vitreoretinopathy in Retinal Detachment Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-15 Francesco Sabatino MD, Philip Banerjee FRCOphth, Mahiul M. K. Muqit FRCOphth
Proliferative vitreoretinopathy (PVR) is an abnormal and prolonged healing response to retinal injury (retinal detachment, post-retinal detachment surgery) characterised by: pre/subretinal membrane formation; retinal gliosis and retinal shortening, retinal pigment epithelium cell proliferation; and increased glial (mainly Mu¨ller cells), fibroblast and inflammatory cell (macrophage, lymphocyte) activity
-
Current management options for the treatment of refractory postoperative cystoid macular Edema: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-14 Layla J Bunjo MBBS, Stephen Bacchi MBBS PhD, James Pietris MD, Weng Onn Chan MBBS PhD
Post-operative cystoid macular edema (PCME) is an important complication following intraocular surgery that often resolves spontaneously without treatment. In some cases, PCME may persist despite initial medical therapy, which can adversely impact visual outcomes. Various topical, intraocular and systemic treatments exist for the prevention and management of cystoid macular edema; however, there is
-
Clinical Challenge: Looking beyond blurred margins Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-13 Jimmy S. Chen, Bobby S. Korn, Andrew R. Carey, Peter J. Savino
A 60-year-old man presented to an outside ophthalmology clinic with 1 month of progressive vision loss in the right eye (OD). Right optic disc edema was noted. Brain and orbit magnetic resonance imaging revealed right optic nerve and left occipital lobe enhancement. He was seen initially by neurology and neurosurgery and subsequently referred to neuro-ophthalmology for consideration of optic nerve
-
Clinical outcome measures in vision and eye care Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-13 Luke Leidy, Anna Dickinson, Pradeep Ramulu, Joshua Ehrlich, Mona A Kaleem
Traditionally, clinical outcome assessments have focused on the patient’s perspective through patient-reported outcome assessments; however, given the complexity, integration, and interactions of various participants within the clinical ophthalmology setting, we propose that additional diverse clinical perspectives should be explored in order to fully appreciate the value of care provided to patients
-
Medication-associated orbital inflammation: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-13 Terence Ang MBBS, Viraj Chaggar, Jessica Y. Tong FRANZCO, Dinesh Selva DHSc FRANZCO FRACS
We performed a comprehensive systematic review to identify medication-associated orbital inflammation and to characterize its clinico-radiological features.
-
Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-03-01 Amparo Ortiz-Seller, Pablo Martorell, Honorio Barranco, Isabel Pascual-Camps, Esteban Morcillo, José L. Ortiz
Laser photocoagulation (LPC) and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections constitute the current standard treatment for retinopathy of prematurity (ROP). This network meta-analysis focus on whether a ranking of interventions may be established for different dose levels of intravitreal injection of anti-VEGF agents (aflibercept, bevacizumab, conbercept, ranibizumab)
-
The complement system and diabetic retinopathy Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-23 Feipeng Jiang, Chunyan Lei, Yingying Chen, Nenghua Zhou, Meixia Zhang
Diabetic retinopathy (DR) is one of the common microvascular complications of diabetes mellitus and is the main cause of visual impairment in diabetic patients. The pathogenesis of DR is still unclear. The complement system, as an important component of the innate immune system in addition to defending against the invasion of foreign microorganisms, is involved in the occurrence and development of
-
REPLY TO: CHAN ET AL. “TEMPORAL ARTERITIS: NEUROLOGICAL AND OPHTHALMOLOGICAL INVOLVEMENT IN THE ABSENCE OF DOCUMENTED SYSTEMIC FEATURES” Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-21 Francesco Pellegrini
-
Temporal arteritis: Neurological and ophthalmological involvement in the absence of documented systemic features Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-20 Jian S. Chan, Dimitria Dimitrovski, William Huang, Geraldine Yang, Peter J. Tweedie, Lloyd R. Kopecny, Shraddha Tipirneni, Grace A. Borchert, Catherine M.H. Ouyang, Amy T.W. Tsoi, Aadhavi Vasanthan, Mina Rezkalla, Natalie S. Lee, James R. Gunasegaram, Aleeza Fatima, Alexandra Allende, Kerrie V. Meades, Susan C. Gaden, Ashish Agar FRANZCO, Ian C. Francis FRACS FRANZCO
-
A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-08 Hatem A. Tawfik, Mohammad Javed Ali
We aim to provide a detailed and updated literature review on the epidemiology, etiology, clinical presentations, histopathology, and ultrastructural features of punctal stenosis. There are inconsistencies in the definition and staging of punctal stenosis. While advanced optical coherence tomography imaging techniques have revolutionized the way the punctum and vertical canaliculi are assessed or monitored
-
Corrigendum to “Future directions in managing aniridia-associated keratopathy” [Surv Ophthalmol 68 (2023) 940–956] Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-06 Arianne J.H. van Velthoven, Tor P. Utheim, Maria Notara, Dominique Bremond-Gignac, Francisco C. Figueiredo, Heli Skottman, Daniel Aberdam, Julie T. Daniels, Giulio Ferrari, Christina Grupcheva, Carina Koppen, Mohit Parekh, Thomas Ritter, Vito Romano, Stefano Ferrari, Claus Cursiefen, Neil Lagali, Vanessa L.S. LaPointe, Mor M. Dickman
-
Hitting the refractive target in corneal endothelial transplantation triple procedures: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-02 Rosa Giglio, Alex Lucia Vinciguerra, Alberto Grotto, Serena Milan, Daniele Tognetto
In phakic patients, Descemet stripping automated endothelial keratoplasty (DSAEK) or Descemet membrane endothelial keratoplasty (DMEK) are frequently combined with phacoemulsification and intraocular lens (IOL) implantation (triple procedure). This surgery might cause a refractive shift difficult to predict. Early DMEK and DSAEK results have shown a tendency toward a hyperopic shift. Myopic postoperative
-
Choroidal thickness in eyes of rheumatoid arthritis patients measured using optical coherence tomography: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-02-01 Sepehr Fekrazad, Mohammad Shahrabi Farahani, Mohammad Amin Salehi, Golnar Hassanzadeh, J. Fernando Arevalo
Rheumatoid arthritis (RA), an autoimmune disease, affects eyes in 25% of cases. Retinal alterations in RA can function as biomarkers as early risk indicators for developing sight-threatening conditions. Optical coherence tomography (OCT) provides high-resolution images of the retina and its component’s thickness measures. The purpose of this review is to compare the choroidal thickness (CT) of RA patients
-
Quality assurance in corneal transplants: Donor cornea assessment and oversight Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-01-08 Vito Romano, Maria Laura Passaro, Alessandro Ruzza, Mohit Parekh, Matteo Airaldi, Hannah J Levis, Stefano Ferrari, Ciro Costagliola, Francesco Semeraro, Diego Ponzin
The cornea is the most frequently transplanted human tissue, and corneal transplantation represents the most successful allogeneic transplant worldwide. In order to obtain good surgical outcome and visual rehabilitation and to ensure the safety of the recipient, accurate screening of donors, and donor tissues is necessary throughout the process. This mitigates the risks of transmission to the recipient
-
Causes of Infectious Pediatric Uveitis; a review Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-01-03 Yaninsiri Ngathaweesuk, Jytte Hendrikse, Jolanda Dorothea Francisca de Groot-Mijnes, Joke Helena de Boer, Ymkje Marije Hettinga
Infectious pediatric uveitis is a rare disease that can cause severe ocular damage if not detected rapidly and treated properly. Additionally, early identification of an infection can protect the child from life-threatening systemic infection. Infectious uveitis can be congenital or acquired and may manifest as a primary ocular infection or as a reactivation. Nevertheless, publications on infectious
-
Good syndrome and cytomegalovirus retinitis: A literature review. Surv. Ophthalmol. (IF 5.1) Pub Date : 2024-01-02 Carolina Cantu-Rosales, Pablo Baquero-Ospina, Samuel Peña-Ortiz, Jahzeel Díaz-Castillo, Luz-Elena Concha-del-Rio
Good Syndrome (GS) is a rare primary immunodeficiency in adults consisting of hypogammaglobulinemia and thymoma that affects both cellular and humoral immunity. It usually appears in patients between the 4th and 6th decade of life and affects both genders equally. Ophthalmological clinical presentation is highly variable; associations with herpetic keratitis, toxoplasmosis, and cytomegalovirus retinitis
-
Diagnostic methods for primary vitreoretinal lymphoma: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-12-30 Ryan S. Huang, Andrew Mihalache, Marko M. Popovic, Miguel Cruz-Pimentel, Bhadra U. Pandya, Rajeev H. Muni, Peter J. Kertes
Primary vitreoretinal lymphoma is a potentially aggressive intraocular malignancy with poor systemic prognosis and sometimes significant diagnostic delays as it may masquerade as chronic uveitis. Despite the variety of diagnostic techniques, it is unclear which modality is most accurate in the diagnosis of PVRL.A systematic literature search was conducted on Ovid MEDLINE, EMBASE and the Cochrane Controlled
-
Subretinal hyperreflective material (SHRM) in retinal and chorioretinal disorders: A comprehensive review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-12-29 Alessandro Feo, Elisa Stradiotto, Riccardo Sacconi, Matteo Menean, Giuseppe Querques, Mario R Romano
Subretinal hyperreflective material (SHRM) is a common and remarkable optical coherence tomography (OCT) biomarker whose importance is emerging in several retinal and chorioretinal diseases, including age-related macular degeneration, central serous chorioretinopathy, polypoidal choroidal vasculopathy, pathologic myopia, posterior uveitis, vitelliform lesions and macular dystrophies, and more rare
-
Multicolour Imaging: Current Clinical Applications Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-12-19 Rupak Roy, Surabhi Chattree, Urvashi Kala, Bristi Majumdar, Janhavi Desai, Sampurna Bhattacharya, Ahana Sen, Sugandha Goel, Nicey Roy Thomas, Maitreyi Chowdhury, Kalpita Das, Eesh Nigam, Debmalya Das, Kumar Saurabh
Multicolor (MC) imaging is an innovative, pseudocolor fundus imaging modality based on confocal scanning laser ophthalmoscopy. It effectively scans the retina at different depths to create a composite image. The green reflectance image depicts the middle retinal while blue reflectance image provides images of the retinal surface. The infrared reflectance image depicts retinal structures at the level
-
Diagnostic accuracy of artificial intelligence in detecting retinitis pigmentosa: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-12-01 Ayman Mohammed Musleh, Saif Aldeen AlRyalat, Mohammad Naim Abid, Yahia Salem, Haitham Mounir Hamila, Ahmed B. Sallam
Introduction Retinitis pigmentosa (RP) is often undetected in its early stages. Artificial intelligence (AI) has emerged as a promising tool in medical diagnostics. Therefore, we conducted a systematic review and meta-analysis to evaluate the diagnostic accuracy of AI in detecting RP using various ophthalmic images. We conducted a systematic search on PubMed, Scopus, and Web of Science databases on
-
Hypomorphic variants in inherited retinal and ocular diseases: A review of the literature with clinical cases Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-29 Tobin B.T. Thuma, Rebecca A. Procopio, Hiram J. Jimenez, Kammi B. Gunton, Jose S. Pulido
Hypomorphic variants decrease, but do not eliminate, gene function via a reduction in the amount of mRNA or protein product produced by a gene or by production of a gene product with reduced function. Many hypomorphic variants have been implicated in inherited retinal diseases (IRDs) and other genetic ocular conditions; however, there is heterogeneity in the use of the term “hypomorphic” in the scientific
-
Peripapillary Fluid: Obvious and Not So Obvious! Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-26 Supriya Arora, Dinah Zur, Claudio Iovino, Jay Chhablani
Intraretinal or subretinal fluid in the peripapillary area can be clinically visualized in conditions such as peripapillary choroidal neovascularization, optic disc pit maculopathy, and optic nerve head tumors and granulomas. Optical coherence tomography (OCT) helps to visualize peripapillary fluid in many other chorioretinal conditions such as peripapillary pachychoroid syndrome, posterior uveitis
-
The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-24 Anubhav Garg, Keean Nanji, Felicia Tai, Mark Phillips, Dena Zeraatkar, Sunir J. Garg, SriniVas R. Sadda, Peter K. Kaiser, Robyn H. Guymer, Sobha Sivaprasad, Charles C. Wykoff, Varun Chaudhary
With the introduction of therapies to treat geographic atrophy (GA), GA management in clinical practice is now possible. A living systematic review can provide access to timely and robust evidence synthesis. This review found that complement factor 3 and 5 (C3 and C5) inhibition compared to sham likely reduces change in square root GA area at 12 months and untransformed GA area at 24 months. There
-
-
Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-23 Stella Weng Chi Sio, Benson Kang To Chan, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, Kenneth Ka Hei Lai, Clement Chee Yung Tham, Chi Pui Pang, Kelvin Kam Lung Chong
Diagnosis of dysthyroid optic neuropathy (DON) typically relies on a set of diagnostic clinical features, including decreased visual acuity, impaired color vision, presence of relative afferent pupillary defect, optic disc swelling and ancillary tests including visual field (VF), pattern visual evoked potential (pVEP), and apical crowding or optic nerve stretching on neuroimaging. We summarize various
-
Planet of the Apex Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-23 Francesco Pellegrini, Maria Basciu, Rod Foroozan
A 63-year-old man with diabetes presented with unilateral ptosis and an exotropia. A diagnosis of isolated diabetic III nerve palsy was made. Subsequent neuro-ophthalmologic evaluation showed multiple cranial nerves involvement consistent with a diagnosis of orbital apex syndrome. Review of past medical history was significant for a previous nasopharyngeal carcinoma and biopsy of the involved site
-
Age-related macular degeneration and neurodegenerative disorders: Shared pathways in complex interactions Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-23 Sayena Jabbehdari, Anthony C. Oganov, Fateme Rezagholi, Soheil Mohammadi, Hamid Harandi, Ghasem Yazdanpanah, J. Fernando Arevalo
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the elderly, and neurodegenerative disorders such as Alzheimer' disease and Parkinson disease are debilitating conditions that affect millions worldwide. Despite the different clinical manifestations of these diseases, growing evidence suggests that they share common pathways in their pathogenesis including inflammation
-
International incidence and temporal trends for rhegmatogenous retinal detachment: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-23 Jasmine Yaowei Ge, Zhen Ling Teo, Miao Li Chee, Yih-Chung Tham, Tyler Hyungtaek Rim, Ching-Yu Cheng, Tien Yin Wong, , Edmund Yick Mun Wong, Shu Yen Lee, Ning Cheung
We set out to estimate the international incidence of rhegmatogenous retinal detachment (RRD), and to evaluate its temporal trend over time. There is a lack of robust estimates on the worldwide incidence and trend for RRD, a major cause of acute vision loss. We conducted a systematic review of RRD incidence. The electronic databases PubMed, Scopus, and Thomson Reuters’ Web of Science were searched
-
In praise of povidone-iodine application in ophthalmology Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-08 Mohammad Soleimani, Ali A. Haydar, Kasra Cheraqpour, Haniyeh Zeidabadinejad, Amirreza Esfandiari, Niloofarsadaat Eshaghhosseiny, Alireza Shahmohammadi, Soraya Banz, Ali R. Djalilian
Polyvinyl pyrrolidone or povidone-iodine (PVP-I) is a water-soluble complex formed by the combination of iodine and a water-soluble polymer, polyvinyl pyrrolidone. This complex exerts bactericidal, fungicidal, and virucidal action by gradually releasing free iodine at the site of application to react with pathogens. In ophthalmology, PVP-I is used as a disinfectant and antiseptic agent for preoperative
-
Cataractogenesis and molecular pathways, with reactive free oxygen species as a common pathway Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-11-07 Arturo Iván Pérez Pacheco
Slowing down or stopping the natural process of cataractogenesis is certainly a challenge for those who today propose an option other than surgery. Addressing the same problem in different ways constitutes a new approach to solving what is today the number one cause of reversible blindness worldwide. The technological revolution, as well as the advances in the biological sciences, allows us to conceive
-
Clinical utilisation of microperimetry in ophthalmic surgery: a narrative review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-31 Timothy Kalas, Alexander Newman, Jonathan Whyte, Abhishek Sharma
Microperimetry is an emerging technology that provides concurrent analysis of retinal structure and function by combining retinal sensitivity and fixation analysis with fundus imaging. We summarize the substantial evidence validating the evolving role of microperimetry as an adjunctive assessment of visual function in the perioperative setting. We show that microperimetry provides useful complementary
-
Not just any headache Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-29 Janet Fan, Pamela Davila, Noor Laylani, Andrew G. Lee, Benjamin Frishberg
A 40-year-old man with a history of traumatic retinal detachment in the left eye treated with scleral buckle and migraine with aura presented to clinic for persistent blurry vision of the right eye following an episode of migraine with aura. The patient had experienced migraines with visual auras starting as a teenager, which normally resolve within an hour except for the most recent episode. Humphrey
-
Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-26 Asim Ali, Leonard Bielory, Stephanie Dotchin, Patrick Hamel, Yi Ning J. Strube, Euna B. Koo
Vernal keratoconjunctivitis (VKC) is a chronic, progressive, and potentially sight-threatening form of ocular inflammatory disease that primarily affects children and young adults. Prevalence varies by region, ranging from <2 per 10,000 in in the United States to as high as 1,100 per 10,000 in parts of Africa. The rarity of VKC in developed countries can make differential diagnosis challenging, and
-
Unusual conjunctival melanocytic proliferations. Report of five cases and review of the literature Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-27 Adrianna Eder, Tatyana Milman, Hardeep-Singh Mudhar, Sara E. Lally, Carol L. Shields, Khanh Bui, Jill R. Wells, Hans E. Grossniklaus
Indeterminate melanocytic proliferations of the conjunctiva have both benign and malignant features that previously made these lesions nearly impossible to categorize in existing classification schemes. With the evolution of immunohistochemistry and molecular genetics, however, subclassifications have emerged that allow for a more tailored diagnosis and management. These conjunctival melanocytic proliferations
-
Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2 Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-27 Ahmed M. Hagag, Rebecca Kaye, Vy Hoang, Sophie Riedl, Philipp Anders, Beth Stuart, Ghislaine Traber, Christian Appenzeller-Herzog, Ursula Schmidt-Erfurth, Hrvoje Bogunovic, Hendrik P. Scholl, Toby Prevost, Lars Fritsche, Daniel Rueckert, Sobha Sivaprasad, Andrew J. Lotery
There is a need to identify accurately prognostic factors that determine the progression of intermediate to late-stage age-related macular degeneration (AMD). Currently, clinicians cannot provide individualised prognoses of disease progression. Moreover, enriching clinical trials with rapid progressors may facilitate delivery of shorter intervention trials aimed at delaying or preventing progression
-
Response to “Observations on the association between Obstructive Sleep Apnea and Floppy Eyelid Syndrome: A systematic review and meta-analysis” Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-07 Alex Jia Yang Cheong, Owen Tsung Wen Ho, Sean Kang Xuan Wang, Chang Yi Woon, Anna See, Adele Chin Wei Ng, Shaun Ray Han Loh, Soon-Phaik Chee, Song Tar Toh
Abstract not available
-
Observations on the association between obstructive sleep apnea and floppy eyelid syndrome: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-07 Jian S. Chan, Matthew K. Lee, Peter J. Tweedie, Claudia J. Tiong, Amy T. Tsoi, Aadhavi Vasanthan, Jed Maegraith, Grace A. Borchert, James R. Gunasegaram, Anna M. Waldie, Geoff Wilcsek Franzco, Ian C. Francis
Abstract not available
-
The role of intravitreal anti-vascular endothelial growth factor injection in peripheral exudative hemorrhagic chorioretinopathy: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-06 Akash Gowda, Bobak Bahrami, Wilson Wong Jun Jie, Robert Casson, Weng Onn Chan
Anti-vascular endothelial growth factor (anti-VEGF) injections have revolutionised the field of ophthalmology, and their use in a variety of retinal diseases is growing. One target disease is peripheral exudative haemorrhagic chorioretinopathy (PEHCR), a disease that is uncommon and poorly understood. Despite this, there are numerous studies and case reports outlining the potential role of intravitreal
-
Ocular surface toxicities associated with modern anticancer therapies Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-06 Rafael Boucher, Oscar Haigh, Emmanuel Barreau, Stéphane Champiat, Olivier Lambotte, Clovis Adam, Marc Labetoulle, Antoine Rousseau
Cancer treatments have recently shifted from broad-spectrum cytotoxic therapies to more focused treatments, maximizing anti-cancerous activity while reducing toxicity to healthy cells. These modern anticancer therapies (MATs) encompass a wide range of innovative molecules that mainly include immune checkpoint inhibitors (ICIs) and targeted anticancer therapies (TATs), comprising antibody drug conjugates
-
Review of smartphone funduscopy for diabetic retinopathy screening Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-06 Neil Vaughan
I detail advances in fundoucopy diagnosis systems integrating smartphones. Smartphone funduscopy devices are comprised of lens devices connecting with smartphones and software applications to be used for mobile retinal image capturing and diagnosis of diabetic retinopathy. This is particularly beneficial to automate and mobilize retinopathy screening techniques and methods in remote and rural areas
-
Anterior chamber inflammation grading methods: A critical review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-05 Hnin Hnin Oo, Madhuvanthi Mohan, Wenjun Song, William Rojas-Carabali, Edmund Tsui, Alejandra de-la-Torre, Carlos Cifuentes-González, Andres Rousselot, Sangly P. Srinivas, Tariq Aslam, Vishali Gupta, Rupesh Agrawal
Assessing anterior chamber (AC) inflammation is highly subjective and challenging. Although various grading systems attempt to offer objectivity and standardization, the clinical assessment has high interobserver variability. Traditional techniques, such as laser flare meter and fluorophotometry, are not widely used since they are time-consuming. With the development of optical coherence tomography
-
Early diabetic eye damage: Comparing detection methods using diagnostic power Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-10-04 Bhim B. Rai, Joshua P. van Kleef, Faran Sabeti, Robin Vlieger, Hanna Suominen, Ted Maddess
It is now clear that retinal neuropathy precedes classical microvascular retinopathy in diabetes. Therefore, tests that underpin useful new endpoints must provide high diagnostic power well before the onset of moderate diabetic retinopathy. Hence, we compare detection methods of early diabetic eye damage. We reviewed data from a range of functional and structural studies of early diabetic eye disease
-
Adaptive optics imaging in inherited retinal diseases: A scoping review of the clinical literature Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-09-29 Alexis Ceecee Britten-Jones, Lawrence Thai, Jeremy P.M. Flanagan, Phillip A. Bedggood, Thomas L. Edwards, Andrew B. Metha, Lauren N. Ayton
Adaptive optics (AO) imaging enables direct, objective assessments of retinal cells. Applications of AO show great promise in advancing our understanding of the etiology of inherited retinal disease (IRDs) and discovering new imaging biomarkers. This scoping review systematically identifies and summarizes clinical studies evaluating AO imaging in IRDs. Ovid MEDLINE and EMBASE were searched on February
-
Ocular toxicities of fibroblast growth factor receptor inhibitors: A review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-09-28 Jerry Hsu, Jasmine H. Francis, Sumayya Ahmad
Fibroblast growth factor receptor (FGFR) inhibitors are an emerging class of small molecule targeted cancer drugs with promising therapeutic possibilities for a wide variety of malignancies. While ocular adverse events from FGFR inhibitors are reported in clinical trials, subsequent case studies continue to reveal new toxicities. Disease pathology affecting multiple parts of the eye has been reported
-
Antiviral treatment for acute retinal necrosis: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-09-27 Ikhwanuliman Putera, Asri Salima Ridwan, Metta Dewi, Carlos Cifuentes-González, William Rojas-Carabali, Ratna Sitompul, Lukman Edwar, Made Susiyanti, Yulia Aziza, Carlos Pavesio, Soon-Phaik Chee, Padmamalini Mahendradas, Jyotirmay Biswas, John H. Kempen, Vishali Gupta, Alejandra de-la-Torre, Rina La Distia Nora, Rupesh Agrawal
Acute retinal necrosis is a progressive intraocular inflammatory syndrome characterized by diffuse necrotizing retinitis that can lead to a poor visual outcome, mainly from retinal detachment. The antiviral treatment approach for acute retinal necrosis varies as there are no established guidelines. We summarize the outcomes of acute retinal necrosis with available antiviral treatments. Electronic searches
-
Refractive surgical correction and treatment of keratoconus Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-09-27 Francesco D’Oria, Simone A. Bagaglia, Jorge L. Alio del Barrio, Giovanni Alessio, Jorge L. Alio, Cosimo Mazzotta
Keratoconus is an ectatic corneal disorder that causes severe vision loss. Surgical options allow us to correct, partially or totally, the induced refractive error. Intracorneal ring segments (ICRS) implantation represents a minimally invasive surgical option that improves visual acuity, with a high success rate and a low overall complication rate. Corneal allogenic ICRS consists of ring segments derived
-
-
Barriers to care in neovascular age-related macular degeneration: Current understanding, developments, and future directions Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-09-15 Alison Choi, Baraa S. Nawash, Katherine Du, Joshua Ong, Jay Chhablani
Neovascular age-related macular degeneration is the advanced and irreversible stage of age-related macular degeneration, the leading cause of severe vision loss in older adults. While anti-vascular endothelial growth factor injections have been shown to preserve or improve vision quality in eyes with neovascular age-related macular degeneration, the treatment regimen can be demanding of patients and
-
Histological changes in retinal detachment: A systematic review for the clinician Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-08-30 Isabela Martins Melo, Tianwei Ellen Zhou, Flavia Nagel, Nikhil S. Patil, Fathima Afira Faleel, Marko Popovic, Rajeev H. Muni
Although there have been numerous innovations in the management of retinal detachment (RD) over the past decades, there is still limited understanding of the pathophysiological processes that take place before and after repair. Summarizing key concepts using animal studies may allow for a better assessment of common pre- and postoperative microstructural abnormalities in RD. We performed a systematic
-
Cataract surgery following refractive surgery: Principles to achieve optical success and patient satisfaction Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-08-26 Tanner J. Ferguson, J. Bradley Randleman
A growing number of patients with prior refractive surgery are now presenting for cataract surgery. Surgeons face a number of unique challenges in this patient population that tends to be highly motivated to retain or regain functional uncorrected acuity postoperatively. Primary challenges include recognition of the specific type of prior surgery, use of appropriate intraocular lens (IOL) power calculation
-
-
Detection of subclinical microvascular changes in systemic lupus erythematous using optical coherence tomography angiography: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-08-06 André Ferreira, Rafael José Vieira, Maria João Furtado, Miguel Lume, José P. Andrade, Pedro Menéres
Systemic lupus erythematosus (SLE) is a chronic, systemic, autoimmune connective tissue disease that affects several vascular territories. We sought to assess the role of optical coherence tomography angiography in detecting subclinical microvascular alterations in SLE patients. PubMed, Scopus, and Web of Science databases were systematically searched until January 21, 2023. Studies using optical coherence
-
Macular neovascularization in inherited retinal diseases: A review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-08-06 Rachael C. Heath Jeffery, Fred K. Chen
Inherited retinal diseases (IRDs) are the most common cause of blindness in working-age adults. Macular neovascularization (MNV) may be a presenting feature or occurs as a late-stage complication in several IRDs. We performed an extensive literature review on MNV associated with IRDs. MNV is a well-known complication of Sorsby fundus dystrophy and pseudoxanthoma elasticum. Those with late-onset Stargardt
-
Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-28 Xiu Juan Zhang, Xiu Nian Chen, Fang Yao Tang, Simon Szeto, Xiang Tian Ling, Zi Xuan Lin, Clement C. Tham, Chi Pui Pang, Li Jia Chen, Jason C. Yam
Myopic choroidal neovascularization (CNV) is a vision-threatening complication of high myopia. Here, we systematically review cohort, case-control, and cross-sectional studies in PubMed, Embase, and Web of Science, and summarize the associated factors of myopic CNV using meta-analysis where applicable. Among 1,333 records assessed, 50 were found eligible, all having a low-to-moderate risk of bias.
-
New developments in the management of persistent corneal epithelial defects. Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-25 María García-Lorente, Marina Rodríguez-Calvo-de-Mora, José-María Sánchez-González, Davide Borroni, Francisco Zamorano-Martín, Carlos Rocha-de-Lossada
Abstract not available
-
Tamoxifen retinopathy: A comprehensive review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-22 Stephen Tenney, Aruoriwo Oboh-Weilke, David Wagner, Mike Yuan Chen
Tamoxifen is a selective estrogen receptor modulator used mainly for the treatment of breast cancer. Based on the case reports and studies performed to date on the retinal toxicity of tamoxifen, retinopathy appears to occur in as many as 12% of patients taking 20 mg tamoxifen a day for over 2 years. Of this 12%, as many as half develop symptomatic changes in visual acuity. Retinal changes consist primarily
-
Retromode imaging in retinal diseases: A systematic review of the literature Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-20 Georges Sukkarieh, Mohamad Issa, Sebastien Bruneau, Aude Couturier, Ramin Tadayoni
Retromode scanning laser ophthalmoscopy imaging captures a pseudo-3-dimensional image of the ocular fundus. Retromode scanning laser ophthalmoscopy imaging was introduced first in 2008 using the Nidek F-10 scanning laser ophthalmoscope (F-10; Nidek Co., Gamagori, Japan). At that time, no major role was described for this imaging modality. The interest in retromode scanning laser ophthalmoscopy imaging
-
Secondhand smoke exposure and ocular health: A systematic review Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-20 Youjuan Zhang, Xiu Juan Zhang, Nan Yuan, Yu Meng Wang, Patrick Ip, Li Jia Chen, Clement C. Tham, Chi Pui Pang, Jason C. Yam
The toxicology of secondhand smoke (SHS), along with the harm of its exposure to human health, has been generally acknowledged; however, specific evidence is lacking on the association between SHS exposure and ocular health. In this systematic review (PROSPERO registration number: CRD42022247992), we included 55 original articles published by 12 May 2023, which dealt with SHS exposure and ocular disorders
-
GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials Surv. Ophthalmol. (IF 5.1) Pub Date : 2023-07-16 Ishani Kapoor, Swara M. Sarvepalli, David D’Alessio, Dilraj S. Grewal, Majda Hadziahmetovic
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes mellitus. Recent research suggests that GLP-1 RAs may influence diabetic retinopathy (DR). We searched ClinicalTrials.gov for trials comparing FDA-approved GLP-1 RAs to placebo, insulin, or oral antidiabetic medicine. Rates of DR, ocular adverse events, demographics, and clinical characteristics were compared amongst